Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 1158

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1
Chunk 1158
---
 of success. An adverse outcome could subject us to significant liabilities to third parties and force us
to curtail or cease the research and development of our technology.

Parties making claims against
us may obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize our
product candidates. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial
diversion of resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial
damages, including treble damages and attorneys’ fees for willful infringement, pay royalties, redesign our infringing products
or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure. Additionally,
parties making claims against us may be able to sustain the costs of complex patent litigation more effectively than we can because they
have substantially greater resources. Furthermore, because of the substantial amount of discovery required in connection with intellectual
property litigation or administrative proceedings, there is a risk that some of our confidential information could be compromised by disclosure.
In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on
our ability to raise additional funds or otherwise have a material adverse effect on our business, results of operations, financial condition
and prospects.

Issues in the development
and use of AI, including machine learning and computer vision, in Renovaro Cube’s AI platform may result in reputational harm
or liability.

AI is
integrated into Renovaro Cube’s and BioSymetrics’ platforms and is a significant element of each of their business offerings
going forward. As with many developing technologies, AI presents risks, challenges and unintended consequences that could affect its further
development, adoption, and use, and therefore Renovaro Cube’s and BioSymetrics’ business. AI algorithms and training methodologies
may be flawed. Data sets may be insufficient, of poor quality, or contain biased information. Inappropriate or controversial data practices
by data scientists, engineers, and end-users of Renovaro Cube’s or BioSymetrics’ systems could impair the acceptance
of AI solutions. If the analyses that AI applications assist in producing are deficient or inaccurate, Renovaro Cube or BioSymetrics could
be subjected to competitive harm, potential legal liability, and brand or reputational harm. Some uses of AI present ethical issues, and
Renovaro Cube’s or BioSymetrics’